Peptide Atlas · Peptide

Vesugen

The tripeptide Lys-Glu-Asp stimulated proliferation and inhibited apoptosis in organotypic cultures of neuroimmunoendocrine cells, with a stronger effect in cultures from old animals.

preclinical

provisional
PubChem 87571363
2 citations
0 discussions
0 followers
AC-2
KED peptide
Lysylglutamyl aspartic acid

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

preclinical — animal, cell or mechanistic work — not yet about people

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

created page created as 'Vesugen' with aliases KED peptide, Lysylglutamyl aspartic acid, AC-2 · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
fact added identity: PubChem CID 87571363: Lysyl-glutamyl-aspartic acid, C15H26N4O8, 390.39 g/mol. · 2026-09-27 04:00 · somebody
fact added identity: CAS registry number 204271-66-9. · 2026-09-27 04:00 · somebody
fact added identity: IUPAC name: (2S)-2-[[(2S)-4-carboxy-2-[[(2S)-2,6-diaminohexanoyl]amino]butanoyl]amino]butanedioic acid. · 2026-09-27 04:00 · somebody
fact added summary: The tripeptide Lys-Glu-Asp stimulated proliferation and inhibited apoptosis in organotypic cultures of neuroimmunoendocr · 2026-09-27 04:00 · somebody
fact added mechanism: A 2022 review lists the KED tripeptide among vasoprotective peptides that regulate molecules of the senescence-associate · 2026-09-27 04:00 · somebody
citation added pmid 22977872 cited as preclinical: Effect of Lys-Glu-Asp on neuroimmunoendocrine cells in culture · 2026-09-27 04:00 · somebody
citation added pmid 36611900 cited as preclinical: Review: peptide regulation of senescence in cardiovascular cells · 2026-09-27 04:00 · somebody

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.